by European Public Health Alliance | May 3, 2019 | Opinion
On 3 April, EPHA members VAS-European Independent Foundation in Angiology/Vascular Medicine organised an event in the European Parliament to raise awareness of vascular diseases, with a focus on PAD (Peripheral Arterial Disease). Hosted by MEP Aldo Patriciello (IT,...
by European Public Health Alliance | May 3, 2019 | Opinion
As part of the European Policy Centre’s current series of events on digitalisation, a recent event organised on 8 April addressed the potential impacts of new technologies on healthcare, with a particular focus on healthcare professionals. To what extent is the...
by European Public Health Alliance | May 3, 2019 | Opinion
As trade and investment agreements increasingly focus on “non-tariff barriers” their potential impacts on public health increase. Trade agreements can affect many issues including their impact on antimicrobial resistance which is often overlooked. Unhealthy Trade?...
by European Public Health Alliance | May 3, 2019 | Opinion
By Jean-Yves Stenuick, Pharmaceuticals Policy & Projects Officer, Health Care Without Harm (HCWH) Europe The European Commission is failing to mitigate the impact of pharmaceutical pollution, a driver of growing antimicrobial resistance recognised by UN...
by European Public Health Alliance | May 3, 2019 | Opinion
By Rose Gallagher MBE, Professional Lead Infection Prevention & Control, Royal College of Nursing and EPHA Scientific Advisor on Antimicrobial Resistance There’s no doubt that awareness of antimicrobial resistance is increasing – within civil society,...
by European Public Health Alliance | May 3, 2019 | Opinion
Nine decades ago, the world was awed by Fleming’s discovery of penicillin, the first antibiotic which revolutionised medicine and the treatment of bacterial infections. A century later, the situation is bleak – not only can we no longer rely on Fleming’s...
